Company prepares new product launches starting in 2025.

New Survey Shows That Over 90% of Animal Owners Trust and Appreciate Veterinary Teams but Underestimate the Demands of the Profession ...

Tumor-infiltrating clonal hematopoiesis (TI-CH) increased the risk of disease recurrence or death among patients with early ...

Zoetis, an industry leader in animal health, has seen substantial growth in revenues, EBITDA margins, and market share over the last decade. The company’s profitability, scale, diversity, and reach ...

Auto-brewery syndrome produces symptoms of intoxication when ethanol produced by dysregulated gut microbiota exceeds the ...

Boehringer Ingelheim has signed a multi-target collaboration with China’s Suzhou Ribo Life Science and its Swedish unit Ribocure to develop treatments for non-alcoholic or metabolic dysfunction ...

Boehringer Ingelheim’s weight-loss drug candidate ... Boehringer also formed an alliance worth up to $2 billion with China’s Suzhou Ribo Life Science and its Swedish unit Ribocure to develop ...

We recently published a list of 10 Best Low Volatility Stocks to Buy Now. In this article, we are going to take a look at ...

The company revealed a $5.5 billion quarterly charge related to U.S. export restrictions on its H20 GPUS to China and other countries ... a lawyer representing one of the companies, Boehringer ...

Boehringer Ingelheim and Tessellate Bio, a precision oncology company with a focus on developing novel synthetic lethality approaches, have entered into a research collaboration and global license ...